Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer [Phase 2]
Phase 2 trial evaluating the combination of erlotinib and docetaxel in patients with Stage IV or recurrent breast cancer; results were poste…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing different administration schedules of ABI-007 (Abraxane) with Bevacizumab in metastatic breast cancer; study termina…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer
This document provides an update indicating the completion of a clinical trial evaluating fulvestrant in postmenopausal patients with metast…
-
CLINICAL_TRIALS research · 2012-03-13Clinical Trial Update: Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Phase 2]
This is a Phase 2 trial comparing docetaxel, carboplatin, and trastuzumab versus vinorelbine and trastuzumab in HER-2 positive metastatic br…
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Phase 2]
A Phase 2 trial evaluating neoadjuvant chemotherapy plus Herceptin in HER2-positive stage II-III breast cancer has completed, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [Phase 2]
This document reports on a Phase 2 clinical trial evaluating pyrazoloacridine in women with metastatic breast cancer; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety of GM-CT-01 with and without 5-fluorouracil in patients with solid tumors, including colorecta…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy
This clinical trial update discusses the long-term outcomes of using breast intensity-modulated radiation therapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) [NA]
This clinical trial update reports on evaluating the informational content of setup verification images used during breast radiation therapy…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab [Phase 2]
A Phase 2 trial assessing the combination of trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic breast …
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women
The document reports on a completed NIH-funded clinical trial examining whether fetal, infant, and early childhood exposures influence adult…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer [NA]
This completed clinical trial evaluated sentinel lymph node biopsy and primary tumor gene expression profiling to detect axillary lymph node…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery [Phase 2]
This Phase 2 clinical trial examines molecular marker profiling of axillary lymph nodes to predict response to chemotherapy in locally advan…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Neoadjuvant GW572016 to Treat Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial of GW572016 for breast cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: 99mTc-MIBI SPECT/CT in Breast Malignancy [NA]
The clinical trial evaluating 99mTc-MIBI SPECT/CT in breast cancer was terminated.
-
FDA approval · 2012-03-02FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tykerb (lapatinib) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS research · 2012-03-01Clinical Trial Update: Breast Cancer Registry in Thailand
A Breast Cancer Registry study in Thailand sponsored by Siriraj Hospital with an unknown current status.
-
CLINICAL_TRIALS research · 2012-02-28Clinical Trial Update: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer [Phase 1]
A Phase 1 clinical trial evaluating cyclophosphamide, fludarabine phosphate, aldesleukin, and treated blood cells in various cancers was ter…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer [Phase 2]
Phase 2 clinical trial of Dexrazoxane as a cardioprotective agent in anthracycline-treated breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2012-02-27Clinical Trial Update: Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Clinical trial update on potential biomarkers for bevacizumab-induced hypertension in patients with solid tumors; the study has been termina…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. [Phase 1]
This document reports the results of a Phase 1 bioequivalence study of Vinorelbine tartrate injectable emulsion in patients with advanced ca…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating high-dose chemotherapy with peripheral stem cell transplantation in patients with recurrent or refractory metastati…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: 3-Dimensional Form and Soft Tissue Biomechanics of the Breast
Clinical trial update indicating termination of the study on 3-Dimensional Form and Soft Tissue Biomechanics of the Breast; no therapeutic r…
-
FDA approval · 2012-02-17FDA Approved: HALAVEN — Supplemental Application (BSP Pharmaceuticals SpA)
FDA approved a supplemental application for HALAVEN (eribulin mesylate) submitted by BSP Pharmaceuticals SpA.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy [Phase 3]
Phase 3 trial evaluating whether 3D ultrasound can be reproducibly used by radiation therapists in partial breast image-guided radiation the…